Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Novo Nordisk
Novo Nordisk
Eli Lilly: A Long-Term Growth Stock
Seeking Alpha
Mon, 07/2/12 - 10:42 am
Eli Lilly
diabetes
Bristol-Myers Squibb
Incyte
Merck
Sanofi
Novo Nordisk
NVO Candidate to Step into Phase III
Yahoo/Zacks
Sat, 06/23/12 - 12:05 pm
Novo Nordisk
semaglutide
diabetes
type 2 diabetes
NVO Candidate to Step into Phase III
Yahoo/Zacks
Fri, 06/22/12 - 03:30 pm
Novo Nordisk
semaglutide
diabetes
New Diabetes Drugs May Push Eli Lilly Higher By 2013
Seeking Alpha
Thu, 06/21/12 - 07:39 am
diabetes
Eli Lilly
Astra Zeneca
Bristol-Myers Squibb
Incyte
linagliptin
Novo Nordisk
JNJ
empagliflozin
Boehringer Ingelheim
How To Kill A Drug Company: Reorganize The Life Out Of It
Forbes
Wed, 06/20/12 - 12:38 pm
Novo Nordisk
reorganization
Hostile Takeovers And The Race To Reduce Residual Risk In Heart Disease Patients
Seeking Alpha
Wed, 06/20/12 - 12:38 pm
M&A
heart disease
Human Genome Sciences
Amylin
GSK
Eli Lilly
Merck
Novo Nordisk
Pfizer
Novo Nordisk, JDRF collaborating on R&D for type 1 diabetes
Yahoo/Fly on the Wall
Wed, 06/13/12 - 12:38 pm
JDRF Artificial Pancreas Project
type 1 diabetes
Novo Nordisk
diabetes
Who Got The Most Buzz At The Diabetes Show?
Pharmalot
Wed, 06/13/12 - 12:05 pm
ADA
diabetes
JNJ
Eli Lilly
Novo Nordisk
Sanofi
Bristol-Myers Squibb
Sanofi, Novo Nordisk, Amylin all tout diabetes treatments at ADA
Fierce Pharma
Mon, 06/11/12 - 01:17 pm
Sanofi
Novo Nordisk
ADA
diabetes
Amylin
degludec
Lantus
Victoza
Novo's Victoza Leads To Greater Weight Loss Than Byetta
Bloomberg
Mon, 06/11/12 - 10:47 am
Byetta
diabetes
Victoza
Novo Nordisk
Amylin
FDA extends review of Novo Nordisk's Degludec by 3 mths
Reuters
Fri, 06/8/12 - 11:49 am
FDA
Novo Nordisk
degludec
diabetes
insulin
Sanofi, Novo, Lilly shape up for big insulin fight
Reuters
Wed, 05/30/12 - 10:25 am
Sanofi
Novo Nordisk
Eli Lilly
diabetes
insulin
Lantus
Novo Nordisk Diabetes Drug Approved For Toddlers
Investors.com
Wed, 05/23/12 - 11:52 am
diabetes
Novo Nordisk
Levemir
Novo’s Insulin Pill Quest Is Holy Grail For Diabetics
Bloomberg
Wed, 05/23/12 - 11:45 am
insulin
diabetes
Novo Nordisk
Amylin Goes A Little Wizard Of Oz On Shareholders
Seeking Alpha
Wed, 05/16/12 - 10:58 am
Amylin
AstraZeneca
Bristol-Myers Squibb
Pfizer
Sanofi
Novo Nordisk
M&A
Merck: Will Singulair Expiration Sink Its Stock?
Seeking Alpha
Tue, 05/8/12 - 10:55 am
Merck
Singulair
Novo Nordisk
Eli Lilly
JNJ
AstraZeneca
GSK
Eli Lilly's Valuation May Prove To Be A Good Investment Opportunity
Seeking Alpha
Mon, 05/7/12 - 11:13 am
Eli Lilly
Amylin
GSK
Novo Nordisk
Pfizer
Sanofi
Novo Nordisk Finally Looks (Slightly) Mortal
Seeking Alpha
Sat, 04/28/12 - 12:54 pm
Novo Nordisk
Novo Nordisk plans 15 percent expansion of U.S. work force in 2012
Yahoo
Fri, 04/27/12 - 11:10 am
Novo Nordisk
hirings
Novo Nordisk saw strong Q1 insulin competition -CFO
Reuters
Fri, 04/27/12 - 10:19 am
earnings
insulin
Novo Nordisk
Pages
« first
‹ previous
…
53
54
55
56
57
58
59
60
61
…
next ›
last »